Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Raches EllaBharat Biotech, Hyderabad, IndiaKrishna Mohan VadrevuBharat Biotech, Hyderabad, India. Electronic address: [email protected]Harsh JogdandBharat Biotech, Hyderabad, IndiaSai PrasadBharat Biotech, Hyderabad, IndiaSiddharth ReddyBharat Biotech, Hyderabad, IndiaVamshi SarangiBharat Biotech, Hyderabad, IndiaBrunda GanneruBharat Biotech, Hyderabad, IndiaGajanan SapkalIndian Council of Medical Research-National Institute of Virology, Pune, IndiaPragya D. YadavIndian Council of Medical Research-National Institute of Virology, Pune, IndiaPriya AbrahamIndian Council of Medical Research-National Institute of Virology, Pune, IndiaSamiran PandaIndian Council of Medical Research, New Delhi, IndiaNivedita GuptaIndian Council of Medical Research, New Delhi, IndiaPrabhakar ReddyNizams Institute of Medical Sciences, Hyderabad, IndiaSavita VermaPandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, IndiaSanjay Kumar RaiAll India Institute of Medical Sciences, New Delhi, IndiaChandramani SinghAll India Institute of Medical Sciences, Patna, IndiaSagar Vivek RedkarChandra Sekhar GillurkarJitendra Singh KushwahaSatyajit MohapatraSRM Hospital and Research Centre, Kattankulathur, IndiaVenkat RaoInstitute of Medical Sciences and SUM Hospital, Bhubaneswar, IndiaRandeep GuleriaAll India Institute of Medical Sciences, New Delhi, IndiaKrishna M. EllaBharat Biotech, Hyderabad, IndiaBalram BhargavaIndian Council of Medical Research, New Delhi, India
2021en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba